A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis

A randomized trial of amphotericin B alone or in combination with itraconazole in the treatment of mucocutaneous leishmaniasis

A randomized trial of amphotericin B (AB) alone and in combination with oral itraconazole (IZ) is carried out in two groups of 10 mucocutaneous leishmaniasis patients from Bolivia and Peru. AB+IZ combination is no better than AB monotherapy, as far as efficacy and tolerability are concerned. No anta...

Full description

Bibliographic Details
Main Authors:	Luis Valda Rodriguez, Jean-Pierre Dedet, Virginia Paredtes, Carmelo Mendoza, Fernando Cardenas
Format:	Article
Language:	English
Published:	Instituto Oswaldo Cruz, Ministério da Saúde 1995-08-01
Series:	Memórias do Instituto Oswaldo Cruz.
Subjects:	mucocutaneous leishmaniasis treatmetn amphotericin B itraconazole
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761995000400020

Similar Items

Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate
by: Gregorio Basile, et al.
Published: (2020-08-01)

Successful treatment of cutaneous protothecosis with liposomal amphotericin and oral itraconazole
by: Brendan McMullan, et al.
Published: (2016-06-01)

Chronic mucocutaneous candidiasis
by: Sarita Sasidharanpillai, et al.
Published: (2018-01-01)

Microdilution procedure for antifungal susceptibility testing of Paracoccidioides brasiliensis to amphotericin b and itraconazole
by: E Takahagi-Nakaira, et al.
Published: (2009-01-01)

Drug susceptibility of Aspergillus flavus and A.fumigatus to Itraconazole and Amphotericin B
by: Kazemi A, et al.
Published: (2013-11-01)

An Atypical Presentation of Disseminated Mucocutaneous Leishmaniasis Caused by Leishmania major In Iran
by: Pedram NORMOHAMADPUR, et al.
Published: (2018-03-01)

Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis
by: A. L. Bittencourt, et al.
Published: (1991-03-01)

Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report
by: Tegegne B, et al.
Published: (2020-10-01)

Efficacy of ultraviolet radiation on drug susceptibility of Candida Spp. to itraconazole, fluconazole and amphotericin B
by: Nowrozi H, et al.
Published: (2013-11-01)

Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species
by: Richa Misra, et al.
Published: (2011-01-01)

Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy
by: Schuler, Ulrich, et al.
Published: (2014)

Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital
by: Marta Garrido-Jareño, et al.
Published: (2020-01-01)

Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis
by: Ciro Martins Gomes, et al.
Published: (2015-04-01)

Therapy of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and bacillus Calmette-Guerin: preliminary report
by: Jacinto Convit, et al.
Published: (2004-02-01)

Clinical aspects and relevance of molecular diagnosis in late mucocutaneous leishmaniasis patients in Paraná, Brazil
by: Andréa Thomaz-Soccol, et al.
Published: (2011-06-01)

Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis
by: Vahid Mashayekhi Goyonlo, et al.
Published: (2014-01-01)

Diagnosing Leishmaniasis in the Chronic Pain Management Setting: A Case Study
by: Ilana Urman, Jereen Chowdhury, Rebecca Chanmin, Danessa Bradley, Devi Nampiaparampil
Published: (2019-09-01)

Mucocutaneous Leishmaniasis: clinical markers in presumptive diagnosis Leishmaniose mucosa: marcadores clínicos no diagnóstico presuntivo
by: João Luiz Cioglia Pereira Diniz, et al.
Published: (2011-06-01)

"SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LEISHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE"
by: P. Tabatabaie, et al.
Published: (2004-05-01)

"SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LEISHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE"
by: P. Tabatabaie, et al.
Published: (2004-02-01)

Parasitological diagnosis of mucocutaneous leishmaniasis due to Leishmania b. braziliensis in Bolivia
by: Laure Dimier-David, et al.
Published: (1991-12-01)

Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis
by: Shirzadi MR
Published: (2019-04-01)

Effect of itraconazole on the cornea in a murine suture model and penetrating keratoplasty model
by: Yang Kyung Cho, et al.
Published: (2017-11-01)

Estudo clínico, epidemiológico e terapêutico de 402 pacientes com leishmaniose tegumentar americana atendidos no Hospital Universitário de Brasília, DF, Brasil Clinical, epidemiological and therapeuthic study of 402 patients with american cutaneous leishmaniasis attended at University Hospital of Brasilia, DF, Brazil
by: Roberto Querido Name, et al.
Published: (2005-06-01)

Dermatologic and otorhinolaryngologic manifestations in leishmaniasis
by: Mota, Luiz Alberto Alves, et al.
Published: (2011-07-01)

Laryngeal Leishmaniasis
by: Moraes, Bruno Teixeira de, et al.
Published: (2012-01-01)

Laryngeal Leishmaniasis
by: Bruno Teixeira de Moraes, et al.
Published: (2012-10-01)

Haga su diagnostico Case for diagnosis
by: Victoria Rivelli, et al.
Published: (2008-08-01)

Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
by: Mahshid Mostafavi, et al.
Published: (2019-08-01)

Nota sobre a ocorrência de leishmaniose tegumentar americana na Serra da Cantareira, São Paulo, SP, Brasil A microepidemic outbreak of american mucocutaneous leishmaniasis in S. Paulo, Brazil
by: Nelson Guimarães Proença, et al.
Published: (1979-03-01)

New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment
by: Miguel Angel Chávez-Fumagalli, et al.
Published: (2015-06-01)

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
by: Md Golam Hasnain, et al.
Published: (2018-12-01)

Espundia: a tropical infectious disease making its way to Europe. A case report of nasal mucocutaneous leishmaniasis in the Netherlands
by: A.A. Schenck, et al.
Published: (2020-06-01)

Immunopathology of American cutaneous leishmaniasis
by: Claude Pirmez
Published: (1992-01-01)

Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil
by: Sebastian Vernal, et al.
Published: (2019-04-01)

Visceral Leishmaniasis in Children in Southern Turkey: Evaluation of Clinical and Laboratory Findings and Liposomal Amphotericin B Treatment
by: Barbaros Şahin Karagün, et al.
Published: (2019-06-01)

In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
by: Mohammad Aamir Mirza, et al.
Published: (2012-12-01)

Leishmaniasis cutánea y anfotericina B liposomal: Reporte de caso
by: Juan Diego Vélez L, et al.

MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method
by: Andrew M. Borman, et al.
Published: (2017-05-01)

Clinical, laboratory, and therapeutic characteristics of American tegumentary leishmaniasis in the 15 th State Health Division, Northwest Paraná State, Southern Brazil
by: Priscila Wolf Nassif, et al.